Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NBM-200MP

K-Number: K124041 · 2013-10-17

ApplicantOrsense, Ltd.
Decision Date2013-10-17
Product CodeDQA
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

NBM-200MP is the device name listed in this FDA 510(k) record. The listed applicant is Orsense, Ltd.. It received FDA 510(k) clearance on 2013-10-17 under 510(k) number K124041. The device is classified under product code DQA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NBM-200MP?

NBM-200MP is a medical device that received FDA 510(k) clearance on 2013-10-17. The listed applicant is Orsense, Ltd.. The 510(k) number is K124041.

When did NBM-200MP receive FDA 510(k) clearance?

NBM-200MP received FDA 510(k) clearance on 2013-10-17, under 510(k) number K124041.

Who is the listed applicant for NBM-200MP?

The FDA 510(k) record lists Orsense, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NBM-200MP?

The FDA product code for NBM-200MP is DQA.

Other records listing Orsense, Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DQA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑